Personalisation of therapy for people with type 2 diabetes and cardiovascular disease risk
Feb 14, 2024 - 00:11:56
Radio and PodcastLive Radio & Podcasts
Health
Publication special: SUSTAIN FORTE With Dr Juan Pablo Frías
GLP-1 receptor agonists including semaglutide have been shown to offer benefits for glycemic control, weight loss and cardiovascular protection in type 2 diabetes. But where a patient requires more glycemic control, woul...
Related Episodes
Continue listening to more episodes from Diabetes Knowledge into Practice Podcast.
Effective strategies for encouraging behaviour change
Feb 14, 2024 - 00:14:28
World Diabetes Day – Overcoming Cultural Obstacles to Personalise Diabetes Care
Dec 19, 2023 - 00:13:24
Congress special: Highlights from EASD 2023
Dec 11, 2023 - 00:14:00
Striving for Balance: Achieving Glycemic, Weight, and Cardiorenal Targets in T2D Care
Sep 28, 2023 - 00:12:06
Highlights from ADA 2023
Sep 12, 2023 - 00:19:45
Conference special: EASD 2022 Highlights With Prof. Apostolos Tsapas
Nov 14, 2022 - 00:18:25
Publication special: Data from the SURPASS program With Prof Carol Wysham
Sep 27, 2022 - 00:13:35